Search results for "dopamine receptor"

showing 10 items of 125 documents

Pgc-1α and Nr4a1 Are Target Genes of Circadian Melatonin and Dopamine Release in Murine Retina

2015

Purpose The neurohormones melatonin and dopamine mediate clock-dependent/circadian regulation of inner retinal neurons and photoreceptor cells and in this way promote their functional adaptation to time of day and their survival. To fulfill this function they act on melatonin receptor type 1 (MT1 receptors) and dopamine D4 receptors (D4 receptors), respectively. The aim of the present study was to screen transcriptional regulators important for retinal physiology and/or pathology (Dbp, Egr-1, Fos, Nr1d1, Nr2e3, Nr4a1, Pgc-1α, Rorβ) for circadian regulation and dependence on melatonin signaling/MT1 receptors or dopamine signaling/D4 receptors. Methods This was done by gene profiling using qu…

Malemedicine.medical_specialtyDopamineDNA Mutational AnalysisBiologyMelatonin receptorRetinaMelatoninMiceDopamineInternal medicinemedicineNuclear Receptor Subfamily 4 Group A Member 1AnimalsCircadian rhythmReceptorMelatoninRegulation of gene expressionDNAAdaptation PhysiologicalPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaeye diseasesCircadian RhythmMice Inbred C57BLEndocrinologyGene Expression RegulationDopamine receptorMutationFemalesense organsSignal transductionhormones hormone substitutes and hormone antagonistsmedicine.drugSignal TransductionTranscription Factors
researchProduct

Dopamine-related genes and spontaneous smoking cessation in ever-heavy smokers

2011

Several studies have provided evidence for associations of polymorphisms located in and near dopamine-related genes and nicotine dependence and other smoking-related phenotypes, including pharmacogenetic interactions. Aim: The purpose of the present work was to examine the association of SNPs in the DOPA decarboxylase (DDC), dopamine receptor D2 (DRD2) and dopamine transporter (SLC6A3) genes with smoking cessation in a large retrospective study featuring approximately 900 cessation events. Materials & methods: Data originated from the enrollment questionnaire of the epidemiological ESTHER study of community-dwelling adults aged 50–74 years, conducted in the German state of Saarland bet…

Malemedicine.medical_specialtyGenotypeDopaminemedicine.medical_treatmentmedia_common.quotation_subjectPharmacologyPolymorphism Single NucleotideLinkage DisequilibriumCohort StudiesGermanyDopamine receptor D2Internal medicineEpidemiologyGeneticsmedicineHumansAge of OnsetSurvival analysisAgedmedia_commonDopamine transporterPharmacologyNorepinephrine Plasma Membrane Transport ProteinsbiologyReceptors Dopamine D2business.industryAddictionSmokingTobacco Use DisorderMiddle AgedAbstinenceSurvival AnalysisDopa Decarboxylasebiology.proteinEducational StatusMolecular MedicineSmoking cessationFemaleSmoking CessationbusinessPharmacogeneticsPharmacogenomics
researchProduct

Role of dopamine neurotransmission in the long-term effects of repeated social defeat on the conditioned rewarding effects of cocaine

2016

Numerous studies report that social defeat stress alters dopamine (DA) neurotransmission in several areas of the brain. Alterations of the mesolimbic dopaminergic pathway are believed to be responsible for the increased vulnerability to drug use observed as a result of social stress. In the present study, we evaluated the influence of DA receptors on the long-term effect of repeated social defeat (RSD) on the conditioned rewarding and reinstating effects of cocaine. For this purpose, the D1R antagonist SCH 23390 and the D1R antagonist raclopride were administered 30 min before each social defeat and a cocaine-induced CPP procedure was initiated three weeks later. The expression of the D1R a…

Malemedicine.medical_specialtyHippocampusStatistics NonparametricReceptors DopamineSocial defeatMice03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDopamine Uptake InhibitorsRewardCocaineInternal medicineDopamine receptor D2medicineAnimalsDopamine receptorsBiological PsychiatryCerebral CortexPharmacologyRacloprideSocial stressSCH-23390Dose-Response Relationship DrugDopaminergicAge FactorsBenzazepinesConditioned place preferenceConditioned place preference030227 psychiatryDisease Models AnimalEndocrinologychemistryRacloprideDopamine receptorAnesthesiaConditioning OperantDopamine AntagonistsPsychologySocial defeat stressStress Psychological030217 neurology & neurosurgerymedicine.drug
researchProduct

Dopamine acting through D2 receptors modulates the expression of PSA-NCAM, a molecule related to neuronal structural plasticity, in the medial prefro…

2008

A "neuroplastic" hypothesis proposes that changes in neuronal structural plasticity may underlie the aetiology of depression and the action of antidepressants. The medial prefrontal cortex (mPFC) is affected by this disorder and shows an intense expression of the polysialylated form of the neural cell adhesion molecule (PSA-NCAM), a plasticity-associated molecule, which is expressed mainly in interneurons. The monoamines serotonin, dopamine and noradrenaline are the principal targets of antidepressant action. Pharmacological manipulation of serotonin levels regulates synaptophysin and PSA-NCAM expression in the adult mPFC. However, the involvement of structural plasticity on the antidepress…

Malemedicine.medical_specialtyInterneuronDopamineSynaptophysinPrefrontal CortexNeural Cell Adhesion Molecule L1Synaptic TransmissionDopamine agonistRats Sprague-DawleyDevelopmental NeuroscienceDopamineDopamine receptor D2Internal medicinePhenethylaminesmedicineAnimalsNeuronsAnalysis of VarianceMicroscopy ConfocalNeuronal PlasticityGlutamate DecarboxylaseReceptors Dopamine D2ChemistryDopaminergicDopamine antagonistImmunohistochemistryRatsmedicine.anatomical_structureEndocrinologynervous systemNeurologyDopamine receptorDopamine AgonistsSialic AcidsDopamine AntagonistsHaloperidolNeural cell adhesion moleculeNeurosciencemedicine.drugExperimental Neurology
researchProduct

Hippocampal dopamine receptors modulate the motor activation and the increase in dopamine levels in the rat nucleus accumbens evoked by chemical stim…

2005

A number of studies have shown that chemical stimulation (using N-methyl-D-aspartate (NMDA) infusions) or electrical stimulation of the ventral hippocampus (VH) elicits locomotor activation and sustained increases in nucleus accumbens (NAc) dopamine (DA) levels in rodents. How DA neurotransmission in NAc is involved in these effects has also been well established. However, the modulatory role of the DA receptors located in VH is not yet fully understood. The purpose of this study was to characterize the role played by VH D1 and D2 subtype receptors in both the locomotor activation and NAc DA increases induced by NMDA stimulation of the VH. This was assessed by studying how retrodialysis app…

Malemedicine.medical_specialtyN-MethylaspartateDopamineMicrodialysisStimulationNucleus accumbensMotor ActivityHippocampusNucleus AccumbensReceptors Dopaminechemistry.chemical_compoundDopamineInternal medicineDopamine receptor D2medicineExcitatory Amino Acid AgonistsAnimalsRats WistarNeurotransmitterPharmacologyRacloprideBrain ChemistrySCH-23390Behavior AnimalChemistryReceptors Dopamine D1BenzazepinesStimulation ChemicalRatsPsychiatry and Mental healthDopamine D2 Receptor AntagonistsEndocrinologyDopamine receptorRacloprideDopamine AntagonistsNeurosciencemedicine.drugNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
researchProduct

Hippocampal dopamine receptors modulate cFos expression in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus

2005

Recently, we have shown that D1 and D2 receptors in the ventral hippocampus (VH) modulate both the locomotor activation and the increase in dopamine (DA) levels in the rat nucleus accumbens (NAc) induced by NMDA stimulation of the VH. In the present study we analyze the possible role of VH D1 and D2 receptors in the modulation of the cFos expression in NAc (core and shell subregions) and in dorsal striatum. This was assessed by immunohistochemical analysis of cFos expression in the rat brains after retro-dialysis application of NMDA (50mM, 10 min) into VH, in absence and in presence of either the D1/D5 receptor antagonist SCH 23390 (100 and 250 microM, 60 min) or the D2 receptor antagonist …

Malemedicine.medical_specialtyN-Methylaspartatenucleus accumbensMicrodialysisStriatumNucleus accumbensHippocampusNucleus AccumbensReceptors DopamineCellular and Molecular Neurosciencechemistry.chemical_compoundDopamineDopamine receptor D2Internal medicinemedicineExcitatory Amino Acid AgonistsAnimalsRats WistarPharmacologyRacloprideSCH-23390ChemistryGenes fosBenzazepinesImmunohistochemistryStimulation ChemicalRatsNeostriatumcFosEndocrinologyD2Gene Expression Regulationnervous systemD1NMDADopamine receptorRacloprideNMDA receptorDopamine Antagonistsdopamineventral hippocampusmedicine.drug
researchProduct

The inhibition by dopamine of cholinergic transmission in the isolated guinea-pig ileum. Mediation through alpha-adrenoceptors.

1982

1. Segments of the guinea-pig ileum were incubated in Tyrode's solution containing 3 μM propranolol. Dopamine, like noradrenaline and clonidine, inhibited the twitch response to field stimulation. The inhibitory action of dopamine remained unchanged in the presence of the dopamine uptake inhibitor nomifensine (1 μM). Tissue from reserpine-pretreated amimals was insensitive to tyramine but the response to dopamine was not affected. It is, therefore, assumed that the effect of dopamine is due to a direct receptor stimulation and not to the release of noradrenaline. 2. The inhibitory action of dopamine was not antagonized by the dopamine receptor antagonists cis-flupenthixol, pimozide or dompe…

Malemedicine.medical_specialtyReserpineApomorphineDopamineGuinea PigsStimulationPharmacologyIn Vitro TechniquesSynaptic TransmissionClonidineNorepinephrineDopamineIleumParasympathetic Nervous SystemInternal medicinemedicineAnimalsTolazolinePharmacologyDose-Response Relationship DrugChemistryGeneral MedicineReceptors Adrenergic alphaDomperidoneReceptors AdrenergicApomorphineNomifensineEndocrinologyDopamine receptorDopamine AntagonistsFemaleSulpiridemedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Effects of two selective dopaminergic antagonists on ethologically-assessed encounters in male mice

1993

Abstract 1. Although it is accepted that dopaminergic antagonists suppress aggressive behaviour, the drugs used have been relatively non-selective or specific to the D2 receptor. 2. The selective D1 antagonist, SCH 23390, makes it possible to evaluate the impact of this receptor on aggressive behaviour. 3. The effects of SCH 23390 and Spiperone (a D2 antagonist) on the aggressive behaviour of mice were assessed employing a “standard opponent” test. 4. Both drugs markedly decreased aggressive behaviour whilst increasing immobility. However, whilst SCH 23390 increased immobility to a small extent, Spiperone, produced a general decline in active behaviours. 5. It appears that the D1 receptor i…

Malemedicine.medical_specialtySpiperoneMotor ActivityPharmacologyReceptors DopamineMicechemistry.chemical_compoundDopamine receptor D1Internal medicineDopamine receptor D2medicineAnimalsReceptorPharmacologySCH-23390business.industryAggressionAntagonistDopamine antagonistBenzazepinesAggressionEndocrinologychemistrySpiperonemedicine.symptombusinessmedicine.drugGeneral Pharmacology: The Vascular System
researchProduct

The effect of dopamine on the overflow of endogenous noradrenaline from the perfused rabbit heart evoked by sympathetic nerve stimulation.

1978

1. The effects of dopamine and two dopamine receptor antagonists (pimozide, flupenthixol) on the release of endogenous noradrenaline evoked by electrical stimulation of the postganglionic sympathetic nerves and their influence on cardiac performance were measured in isolated perfused rabbit hearts. 2. Dopamine 0.2μM decreased noradrenaline overflow and ventricular tension development in response to nerve stimulation. 3. Dopamine 2μM increased spontaneous noradrenaline output and tension development. The noradrenaline overflow in response to nerve stimulation was greatly enhanced. This action was only partly reversed by wash out of exogenous dopamine, indicating de novo synthesis and facilit…

Malemedicine.medical_specialtySympathetic Nervous SystemDopamineOxymetazolineStimulationEndogenyFlupenthixolIn Vitro TechniquesNorepinephrinePimozideCocaineDopamineInternal medicinemedicineAnimalsPharmacologyChemistryRabbit heartMyocardiumHeartGeneral MedicineElectric StimulationFlupenthixolEndocrinologyDopamine receptorcardiovascular systemDopamine AntagonistsFemaleRabbitsmedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

2,3,9- and 2,3,11-Trisubstituted tetrahydroprotoberberines as D2 dopaminergic ligands

2013

Dopamine-mediated neurotransmission plays an important role in relevant psychiatric and neurological disorders. Nowadays, there is an enormous interest in the development of new dopamine receptors (DR) acting drugs as potential new targets for the treatment of schizophrenia or Parkinson's disease. Previous studies have revealed that isoquinoline compounds such as tetrahydroisoquinolines (THIQs) and tetrahydroprotoberberines (THPBs) can behave as selective D-2 dopaminergic alkaloids since they share structural similarities with dopamine. In the present study we have synthesized eleven 2,3,9- and 2,3,11-trisubstituted THPB compounds (six of them are described for the first time) and evaluated…

Models MolecularBerberineStereochemistryCell SurvivalMTT and cytofluorometric analysisTheoretical calculationsMolecular Dynamics SimulationLigandsCiencias BiológicasCompostos orgànics SíntesiDrug DiscoveryAlcaloidesDopamina ReceptorsAnimalsHumansTetrahydroprotoberberinesDopamine receptorsStructure-activity relationships cytotoxicityPharmacologyMolecular StructureChemistryReceptors Dopamine D2Organic ChemistryDopaminergicGeneral MedicineBioquímica y Biología MolecularRatsDopamine receptorStructureeactivity relationships cytotoxicityQuímica orgànicaCIENCIAS NATURALES Y EXACTAS
researchProduct